Possibilities and limitations of an in vitro three-dimensional bone marrow model for the prediction of clinical responses in patients with relapsed multiple myeloma

被引:4
作者
Braham, Maaike V. J. [1 ]
Alblas, Jacqueline [1 ]
Dhert, Wouter J. A. [1 ,2 ]
Oner, F. Cumhur [1 ]
Minnema, Monique C. [3 ]
机构
[1] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands
[2] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Hematol, Canc Ctr, Utrecht, Netherlands
关键词
IMMUNOMODULATORY DRUGS;
D O I
10.3324/haematol.2018.213355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E523 / E526
页数:4
相关论文
共 15 条
[1]   Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment [J].
Belloni, Daniela ;
Heltai, Silvia ;
Ponzoni, Maurilio ;
Villa, Antonello ;
Vergani, Barbara ;
Pecciarini, Lorenza ;
Marcatti, Magda ;
Girlanda, Stefania ;
Tonon, Giovanni ;
Ciceri, Fabio ;
Caligaris-Cappio, Federico ;
Ferrarini, Marina ;
Ferrero, Elisabetta .
HAEMATOLOGICA, 2018, 103 (04) :707-716
[2]   Liposomal drug delivery in an in vitro 3D bone marrow model for multiple myeloma [J].
Braham, Maaike V. J. ;
Deshantri, Anil K. ;
Minnema, Monique C. ;
Oner, F. Cumhur ;
Schiffelers, Raymond M. ;
Fens, Marcel H. A. M. ;
Alblas, Jacqueline .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 :8105-8118
[3]   Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model [J].
Braham, Maaike V. J. ;
Minnema, Monique C. ;
Aarts, Tineke ;
Sebestyen, Zsolt ;
Straetemans, Trudy ;
Vyborova, Anna ;
Kuball, Jurgen ;
Oner, F. Cumhur ;
Robin, Catherine ;
Alblas, Jacqueline .
ONCOIMMUNOLOGY, 2018, 7 (06)
[4]   3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma [J].
de la Puente, Filar ;
Muz, Barbara ;
Gilson, Rebecca C. ;
Azab, Feda ;
Luderer, Micah ;
King, Justin ;
Achilefu, Samuel ;
Vij, Ravi ;
Azab, Abdel Kareem .
BIOMATERIALS, 2015, 73 :70-84
[5]   Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience [J].
Holstein, Sarah A. ;
McCarthy, Philip L. .
DRUGS, 2017, 77 (05) :505-520
[6]   A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications [J].
Jakubikova, Jana ;
Cholujova, Danka ;
Hideshima, Teru ;
Gronesova, Paulina ;
Soltysova, Andrea ;
Harada, Takeshi ;
Joo, Jungnam ;
Kong, Sun-Young ;
Szalat, Raphael E. ;
Richardson, Paul G. ;
Munshi, Nikhil C. ;
Dorfman, David M. ;
Anderson, Kenneth C. .
ONCOTARGET, 2016, 7 (47) :77326-77341
[7]   3D in vitro tissue models and their potential for drug screening [J].
Kimlin, Lauren ;
Kassis, Jareer ;
Virador, Victoria .
EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (12) :1455-1466
[8]   A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma [J].
Kirshner, Julia ;
Thulien, Kyle J. ;
Martin, Lorri D. ;
Marun, Carina Debes ;
Reiman, Tony ;
Belch, Andrew R. ;
Pilarski, Linda M. .
BLOOD, 2008, 112 (07) :2935-2945
[9]   Multiple myeloma [J].
Kumar, Shaji K. ;
Rajkumar, Vincent ;
Kyle, Robert A. ;
van Duin, Mark ;
Sonneveld, Pieter ;
Mateos, Maria-Victoria ;
Gay, Francesca ;
Anderson, Kenneth C. .
NATURE REVIEWS DISEASE PRIMERS, 2017, 3
[10]   Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing [J].
Majumder, Muntasir Mamun ;
Silvennoinen, Raija ;
Anttila, Pekka ;
Tamborero, David ;
Eldfors, Samuli ;
Yadav, Bhagwan ;
Karjalainen, Riikka ;
Kuusanmaki, Heikki ;
Lievonen, Juha ;
Parsons, Alun ;
Suvela, Minna ;
Jantunen, Esa ;
Porkka, Kimmo ;
Heckman, Caroline A. .
ONCOTARGET, 2017, 8 (34) :56338-56350